Unknown PHASE3 INTERVENTIONAL 2-arm NCT05764304

Sinomenine Versus Glucocorticoid for Knee OA

Therapeutic Evaluation of Treatment With Sinomenine Versus Glucocorticoid for Early Knee Osteoarthritis: A Prospective, Double-Blind, Randomized, Multicenter Clinical Trial

Sponsor: Shanghai 6th People's Hospital

Conditions Knee Osteoarthritis

Interventions Glucocorticoid Sinomenine

Updated 4 times since 2023 Last updated: Mar 1, 2023 Started: Feb 28, 2023 Primary completion: Feb 27, 2025 Completion: Mar 31, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05764304, this PHASE3 trial focuses on Knee Osteoarthritis and remains ongoing. Sponsored by Shanghai 6th People's Hospital, it has been updated 4 times since 2023, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

May 2025 — Present [monthly]

Unknown PHASE3

Status: Not Yet Recruiting → Unknown
Sep 2024 — May 2025 [monthly]

Not Yet Recruiting PHASE3
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting PHASE3
Apr 2023 — Jul 2024 [monthly]

Not Yet Recruiting PHASE3

First recorded

Feb 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Shanghai 6th People's Hospital

Data source: Shanghai 6th People's Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.